These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20799311)

  • 1. α-ketoheterocycles as inhibitors of Leishmania mexicana cysteine protease CPB.
    Steert K; Berg M; Mottram JC; Westrop GD; Coombs GH; Cos P; Maes L; Joossens J; Van der Veken P; Haemers A; Augustyns K
    ChemMedChem; 2010 Oct; 5(10):1734-48. PubMed ID: 20799311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold compounds as cysteine protease inhibitors: perspectives for pharmaceutical application as antiparasitic agents.
    Massai L; Messori L; Micale N; Schirmeister T; Maes L; Fregona D; Cinellu MA; Gabbiani C
    Biometals; 2017 Apr; 30(2):313-320. PubMed ID: 28283781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of semicarbazones, thiosemicarbazones and triazine nitriles as inhibitors of Leishmania mexicana cysteine protease CPB.
    Schröder J; Noack S; Marhöfer RJ; Mottram JC; Coombs GH; Selzer PM
    PLoS One; 2013; 8(10):e77460. PubMed ID: 24146999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiprotozoal and cysteine proteases inhibitory activity of dipeptidyl enoates.
    Royo S; Schirmeister T; Kaiser M; Jung S; Rodríguez S; Bautista JM; González FV
    Bioorg Med Chem; 2018 Sep; 26(16):4624-4634. PubMed ID: 30037754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,4-Dihydroxy-2,3-dioxatricyclo[8.4.0.0(4,9)]tetradecane and derivatives with in vitro activity against Plasmodium falciparum, Trypanasoma b brucei, Trypanasoma cruzi, and Leishmaniasis infantum.
    Howarth J; Wilson D
    Bioorg Med Chem Lett; 2003 Jun; 13(12):2013-5. PubMed ID: 12781185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
    Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
    Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitrypanosomal and cysteine protease inhibitory activities of alkyldiamine cryptolepine derivatives.
    Lavrado J; Mackey Z; Hansell E; McKerrow JH; Paulo A; Moreira R
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6256-60. PubMed ID: 22926067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis.
    De Luca L; Ferro S; Buemi MR; Monforte AM; Gitto R; Schirmeister T; Maes L; Rescifina A; Micale N
    Chem Biol Drug Des; 2018 Sep; 92(3):1585-1596. PubMed ID: 29729080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.
    Greenbaum DC; Mackey Z; Hansell E; Doyle P; Gut J; Caffrey CR; Lehrman J; Rosenthal PJ; McKerrow JH; Chibale K
    J Med Chem; 2004 Jun; 47(12):3212-9. PubMed ID: 15163200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ensemble-based ADME-Tox profiling and virtual screening for the discovery of new inhibitors of the Leishmania mexicana cysteine protease CPB2.8ΔCTE.
    Scala A; Rescifina A; Micale N; Piperno A; Schirmeister T; Maes L; Grassi G
    Chem Biol Drug Des; 2018 Feb; 91(2):597-604. PubMed ID: 29045053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
    Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
    Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of quinoline derivatives as potential cysteine protease inhibitors.
    Andrade MM; Martins LC; Marques GV; Silva CA; Faria G; Caldas S; Dos Santos JS; Leclercq SY; Maltarollo VG; Ferreira RS; Oliveira RB
    Future Med Chem; 2020 Apr; 12(7):571-581. PubMed ID: 32116030
    [No Abstract]   [Full Text] [Related]  

  • 13. Vinyl sulfone-based inhibitors of trypanosomal cysteine protease rhodesain with improved antitrypanosomal activities.
    Zhang H; Collins J; Nyamwihura R; Crown O; Ajayi O; Ogungbe IV
    Bioorg Med Chem Lett; 2020 Jul; 30(14):127217. PubMed ID: 32527539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl nitrile derivatives have cytostatic effects against Leishmania spp. promastigotes.
    Quilles JC; Tezuka DY; Lopes CD; Ribeiro FL; Laughton CA; de Albuquerque S; Montanari CA; Leitão A
    Exp Parasitol; 2019 May; 200():84-91. PubMed ID: 30954455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of Leishmania mexicana cysteine protease B in complex with a high-affinity azadipeptide nitrile inhibitor.
    Ribeiro JFR; Cianni L; Li C; Warwick TG; de Vita D; Rosini F; Dos Reis Rocho F; Martins FCP; Kenny PW; Lameira J; Leitão A; Emsley J; Montanari CA
    Bioorg Med Chem; 2020 Nov; 28(22):115743. PubMed ID: 33038787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mining a cathepsin inhibitor library for new antiparasitic drug leads.
    Ang KK; Ratnam J; Gut J; Legac J; Hansell E; Mackey ZB; Skrzypczynska KM; Debnath A; Engel JC; Rosenthal PJ; McKerrow JH; Arkin MR; Renslo AR
    PLoS Negl Trop Dis; 2011 May; 5(5):e1023. PubMed ID: 21572521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiprotozoal activity of synthetic amino substituted 1-methyl-1 H-alpha-carbolines.
    Verbeeck S; Yadav AK; Maes BU; Augustyns K; Van Der Veken P; Cos P; Maes L; Pieters L
    Pharmazie; 2014 Feb; 69(2):83-5. PubMed ID: 24640594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the S1 and S1' subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents.
    Cianni L; Lemke C; Gilberg E; Feldmann C; Rosini F; Rocho FDR; Ribeiro JFR; Tezuka DY; Lopes CD; de Albuquerque S; Bajorath J; Laufer S; Leitão A; Gütschow M; Montanari CA
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0007755. PubMed ID: 32163418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.
    Mott BT; Ferreira RS; Simeonov A; Jadhav A; Ang KK; Leister W; Shen M; Silveira JT; Doyle PS; Arkin MR; McKerrow JH; Inglese J; Austin CP; Thomas CJ; Shoichet BK; Maloney DJ
    J Med Chem; 2010 Jan; 53(1):52-60. PubMed ID: 19908842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine protease inhibitors as chemotherapy for parasitic infections.
    McKerrow JH; Engel JC; Caffrey CR
    Bioorg Med Chem; 1999 Apr; 7(4):639-44. PubMed ID: 10353643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.